Annona muricata leaves are traditionally used as an anticancer plant in the world. The aim of this study was to evaluate the ameliorative effect of the essential oil from Annona muricata leaves (EOAm) in an experimental model of breast cancer and to determine the volatile constituents with gas chromatography-mass spectrometry (GC-MS). Thirty female rats were assigned to five groups: the control group; the DMBA (7,12-dimethylbenz[α]anthracene) group; and three groups received daily EOAm doses of 50, 100, and 200 mg/kg/day, plus DMBA, respectively. After 13 weeks of treatment, tumors were analyzed pathologically and biochemical markers in serum were noted. As a result, in GC-MS analysis, 40 compounds were identified and 4 of them were abundant: Z-caryophyllene (40.22%), followed by α-selinene (9.94%), β-pinene (8.92%), and β-elemene (7.48%). Furthermore, EOAm in a dose-dependent form produced a reduction in tumor frequency and the accumulated tumor volume was reduced by 50% and 71% with doses of 100 and 200 mg/kg, respectively. Serum levels of reduced glutathione (GSH) increased and malondialdehyde (MDA) decreased significantly compared to the DMBA group. Serum levels of vascular endothelial growth factor (VEGF) decreased significantly from 70.75 ± 7.15 pg/mL in the DMBA group to 46.50 ± 9.00 and 34.13 ± 11.50 pg/mL in groups treated with doses of 100 and 200 mg/kg, respectively. This study concludes that the EOAm leaves showed an ameliorative effect in a murine model of breast cancer.
Brunfelsia grandiflora is an ancient plant widely used for its promising medicinal properties, although little explored scientifically. Despite being a rich source of phenolic compounds responsible in part for the proven anti-inflammatory activity, its characterization has not been carried out to date. The present work deals with the exhaustive identification and quantification of its phenolic fraction, along with its antioxidant activity. Decoction resulting from the bark as fine powder was filtered and lyophilized, and polyphenols were extracted from the resulting product by aqueous-organic solvents. Seventy-nine polyphenols were identified using LC-MSn. Hydroxycinnamates was the most abundant group of compounds (up to 66.8%), followed by hydroxycoumarins (15.5%), lignans (6.1%), flavonols (5.7%), phenolic simples (3.1), gallates (2.3%), flavanols (0.3%), and flavanones (0.2%). About 64% of the characterized phenols were in their glycosylated forms. The quantification of these phytochemicals by LC-QToF showed that this medicinal plant contained 2014.71 mg of phenolic compounds in 100 g dry matter, which evidences a great antioxidant potency determined by ABTS and DPPH assays. Therefore, Brunfelsia grandiflora represents an important source of polyphenols which supports its therapeutic properties scientifically proven.
Brunfelsia grandiflora is a South American solanaceae widely used since long ago for its recognized medicinal properties. We have recently reported its chemical composition, showing a relevant number of bioactive compounds with antioxidant capacity, and proved the cytoprotective and antioxidative stress potential of B. grandiflora in cultured endothelial cells. Since B. grandiflora extracts have shown effects on the central nervous system, the present study was designed to show the potential cytoprotective capacity and the antioxidative stress potential of phenolic extracts from the plant on cultured neuron-like cells, as a model to reduce the presentation or effects of chronic diseases of the nervous system. To this end, we studied its reactive oxygen species (ROS)-reducing capacity, its antioxidant defense mechanisms, and some molecular markers involved in redox balance and apoptosis. The results show that cell survival and most changes in biomarkers related to oxidative status, ROS, reduced glutathione, glutathione peroxidase and reductase, malondialdehyde, and caspase 3/7 activity, and molecular expression of cell death-related genes (BAX, BNIP3, and APAF1), NFκB, SOD, and NRF2 (genes from oxidative stress—antioxidants) induced by oxidative stress were prevented by either co- or pretreatment of neuron-like cells with B. grandiflora extracts (25–200 µg/mL). The results demonstrate the chemoprotective potential of the plant and support its medicinal use.
The goal of this study was to apply the principles of analytical quality by design (AQbD) to the analytical method for determining the radiochemical purity (PQR) of the radiopharmaceutical sodium iodide 131I oral solution, utilizing thin-layer chromatography (TLC) with a radio–TLC scanner, which also enables the evaluation of product quality. For AQbD, the analytical target profile (ATP), critical quality attributes (CQA), risk management, and the method operable design region (MODR) were defined through response surface methodology to optimize the method using MINITAB® 19 software. This study encompassed the establishment of a control strategy and the validation of the method, including the assessment of selectivity, linearity, precision, robustness, detection limit, quantification limit, range, and the stability of the sample solution. Under the experimental conditions, the method parameters of the TLC scanner were experimentally demonstrated and optimized with an injection volume of 3 µL, a radioactive concentration of 10 mCi/mL, and a carrier volume of 40 µL. Statistical analysis confirmed the method’s selectivity for the 131I iodide band Rf of 0.8, a radiochemical impurity IO3− Rf of 0.6, a linearity from 6.0 to 22.0 mCi/mL, and an intermediate precision with a global relative standard deviation (RSD) of 0.624%. The method also exhibited robustness, with a global RSD of 0.101%, a detection limit of 0.09 mCi/mL, and a quantification limit of 0.53 Ci/mL, meeting the prescribed range and displaying stability over time (at 0, 2, and 20 h) with a global RSD of 0.362%, resulting in consistent outcomes. The development of a method based on AQbD facilitated the creation of a design space and an operational space, with comprehensive knowledge of the method’s characteristics and limitations. Additionally, throughout all operations, compliance with the acceptance criteria was verified. The method’s validity was confirmed under the established conditions, making it suitable for use in the manufacturing process of sodium iodide 131I and application in nuclear medicine services.
12 August 2022 in Evidence-Based Complementary and Alternative Medicine
Peptic ulcer is a universal condition that is a public health problem due to its prevalence, risk of complications and socioeconomic impact. This study aimed to determine the antiulcer effect of the hydroalcoholic extract from Senna multiglandulosa leaves against ethanol-induced gastric ulcer in rats. Thirty-six male albino Holtzman rats were assigned to six groups. Group I received physiological saline (PS) at doses of 10 mL/kg; group II: ethanol (PS + ethanol 5 mL/kg); group III; omeprazole 100 mg/kg/day (gold standard); groups IV, V and VI received doses of 100, 250 and 500 mg/kg/day of S. multiglandulosa extract, respectively. The stomach was removed to determine the ulcerative lesions and two sections of the glandular zone to carry out the analysis of the gastric mucus and sulfhydryl groups content. As result, S. multiglandulosa at doses of 250 and 500 mg/kg produced a significant decrease of the injured area, with values of 46.28 ± 7.95 mm2 and 6.91 ± 2.48 mm2, respectively ( ). The protective effect was showed at dose of 500 mg/kg (92.27%) and a significant increase in the production of mucus with a value of 83.13 ± 13.09 mg/mL/g of tissue (61.14%). The production of nonprotein sulfhydryl groups (NP-SG) also increased significantly at the three evaluated doses, being 250.34 ± 21.16 μg/g tissue at dose of 500 mg/kg (119.94%). It is concluded that S. multiglandulosa extract protected against ethanol-induced gastric ulcer due to increased gastric mucus secretion and its antioxidant activity due to the generation of nonprotein sulfhydryl groups.
Las propiedades de Annona muricata L. (guanábana) se han demostrado en estudios realizados en sus hojas, pulpa, semillas, tallos y cáscara; destacándose en cada una de ellas sus propiedades antioxidantes. En el presente trabajo se realizó la cuantificación de los polifenoles totales y la evaluación de la capacidad antioxidante en el extracto etanólico de las flores de Annona muricata L. (guanábana). Las muestras de flores se recolectaron en la provincia de Jaén (Cajamarca, Perú). El extracto etanólico se obtuvo por maceración de las flores secas pulverizadas. La cuantificación de los polifenoles en el extracto etanólico de las flores se realizó mediante la técnica de Folin-Ciocalteu utilizando el ácido gálico como patrón. La evaluación de la capacidad antioxidante se realizó mediante los métodos de captación de los radicales DPPH y ABTS.+ utilizando el Trolox como patrón para ambos métodos. Los polifenoles totales obtenidos en el extracto etanólico fue de 10,946 ± 0,008 mg EAG/g. Los valores de IC50 fueron de 104,28 µg/mL para el radical DPPH y 73,22 µg/mL para el radical ABTS.+. Según los resultados obtenidos, el extracto etanólico de las flores de Annona muricata L. tiene importante actividad antioxidante, siendo mayor su capacidad neutralizante sobre el radical ABTS.+.
About Me
Norma Julia Ramos Cevallos is a Pharmacist and Biochemist from the National University of San Marcos (UNMSM), Peru. She holds a Master’s degree in University Teaching and Educational Research and earned a PhD in Pharmacy and Biochemistry from UNMSM. She has over 20 years of experience in university teaching. She is the head of the “RETECNO” Research Group at UNMSM and serves as the principal representative of the university in the multisectoral technical group for the prevention and control of smuggling, illegal trade, and falsification of pharmaceutical products, within the Education and Dissemination Commission of CONTRAFALME. She is also the author and co-author of scientific articles published in national and international journals. She has served as former President of the Teaching and Research Sector of the Pharmaceutical Chemists’ Association of Lima, former Head of the Educational Technology Unit of the Faculty of Pharmacy and Biochemistry at UNMSM, and former Manager of SISMED at DISA Lima Norte, among other notable positions.
Norma Julia Ramos Cevallos is a Pharmacist and Biochemist from the National University of San Marcos (UNMSM), Peru. She holds a Master’s degree in University Teaching and Educational Research and earned a PhD in Pharmacy and Biochemistry from UNMSM. She has over 20 years of experience in university teaching. She is the head of the “RETECNO” Research Group at UNMSM and serves as the principal representative of the university in the multisectoral technical group for the prevention and control of smuggling, illegal trade, and falsification of pharmaceutical products, within the Education and Dissemination Commission of CONTRAFALME. She is also the author and co-author of scientific articles published in national and international journals. She has served as former President of the Teaching and Research Sector of the Pharmaceutical Chemists’ Association of Lima, former Head of the Educational Technology Unit of the Faculty of Pharmacy and Biochemistry at UNMSM, and former Manager of SISMED at DISA Lima Norte, among other notable positions.